These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 29543810)

  • 1. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
    La Manna MP; Orlando V; Li Donni P; Sireci G; Di Carlo P; Cascio A; Dieli F; Caccamo N
    PLoS One; 2018; 13(3):e0192664. PubMed ID: 29543810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
    Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
    Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
    Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
    J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
    Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
    Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting.
    Clifford V; Tebruegge M; Zufferey C; Germano S; Forbes B; Cosentino L; Matchett E; McBryde E; Eisen D; Robins-Browne R; Street A; Denholm J; Curtis N
    Tuberculosis (Edinb); 2019 Jan; 114():91-102. PubMed ID: 30711163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
    Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
    Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
    Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
    Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential biomarkers associated with discrimination between latent and active pulmonary tuberculosis.
    Kamakia R; Kiazyk S; Waruk J; Meyers A; Ochanda J; Ball TB; Oyugi J
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):278-285. PubMed ID: 28225338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Immunological Biomarkers for Detection of Mycobacterium tuberculosis Infection in a Setting Where M. tuberculosis Is Endemic, Ethiopia.
    Teklu T; Kwon K; Wondale B; HaileMariam M; Zewude A; Medhin G; Legesse M; Pieper R; Ameni G
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
    J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
    Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
    PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of a cytokine and IFN-γ-induced chemokine mRNA assay after Mycobacterium tuberculosis-specific antigen stimulation in whole blood from infected individuals.
    Kim S; Lee H; Kim H; Kim Y; Cho JE; Jin H; Kim DY; Ha SJ; Kang YA; Cho SN; Lee H
    J Mol Diagn; 2015 Jan; 17(1):90-9. PubMed ID: 25528189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterial-specific secretion of cytokines and chemokines in healthcare workers with apparent resistance to infection with
    Shey MS; Balfour A; Masina N; Bekiswa A; Schutz C; Goliath R; Dielle R; Katoto PD; Wilkinson KA; Lewinsohn D; Lewinsohn DA; Meintjes G
    Front Immunol; 2023; 14():1176615. PubMed ID: 37275871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PpiA antigen specific immune response is a potential biomarker for latent tuberculosis infection.
    Pathakumari B; Anbarasu D; Parthasarathy RT; Raja A
    Tuberculosis (Edinb); 2015 Dec; 95(6):736-743. PubMed ID: 26546406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling the human immune response to Mycobacterium tuberculosis by human cytokine array.
    Chen T; Li Z; Yu L; Li H; Lin J; Guo H; Wang W; Chen L; Zhang X; Wang Y; Chen Y; Liao Q; Tan Y; Shu Y; Huang W; Cai C; Zhou Z; Yu M; Li G; Zhou L; Zhong Q; Bi L; Zhao M; Guo L; Zhou J
    Tuberculosis (Edinb); 2016 Mar; 97():108-17. PubMed ID: 26980502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report.
    Stern JN; Keskin DB; Romero V; Zuniga J; Encinales L; Li C; Awad C; Yunis EJ
    Immunol Res; 2009; 45(1):1-12. PubMed ID: 18648750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.